Beacon Capital Management Inc (Ohio)’s Novo Nordisk NVO Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$479	Hold	10	–	–	﹤0.01%	106
2026 Q1	$368	Hold	10	–	–	﹤0.01%	109
2025 Q4	$509	Hold	10	–	–	﹤0.01%	114
2025 Q3	$555	Hold	10	–	–	﹤0.01%	124
2025 Q2	$690	Buy	+10	New	+$680	﹤0.01%	91
2016 Q1	–	Sell	-8	Closed	–	–	296
2015 Q4	$0	Buy	+8	New	+$221	﹤0.01%	334

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s NVO Position: Q2 2026 in Review

Beacon Capital Management Inc (Ohio) held its Novo Nordisk (NVO) position steady in Q2 2026 at 10 shares worth $479. The position accounts for ﹤0.01% of the portfolio, ranked #106.

Beacon Capital Management Inc (Ohio) first reported a position in NVO in Q4 2015 and has held it in 6 quarters since. The position peaked at $690 in Q2 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Beacon Capital Management Inc (Ohio) held 10 shares of Novo Nordisk worth $479 as of Q2 2026.
Beacon Capital Management Inc (Ohio) left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of Beacon Capital Management Inc (Ohio)'s portfolio in Q2 2026, its #106 holding.
Beacon Capital Management Inc (Ohio) first reported a position in Novo Nordisk in Q4 2015 and has held it in 6 quarters since.
Beacon Capital Management Inc (Ohio)'s Novo Nordisk position peaked at $690 in Q2 2025.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2026, filed 13 Aug 2026.